Editas Medicine Funding: $214M Raised, IPO

Editas Medicine is a Biotech company based in Cambridge, Massachusetts. It has raised $214M in total funding. Latest round: IPO. Backed by Bill Gates.

Editas Medicine funding overview

Editas Medicine is a Biotech company based in Cambridge, Massachusetts. Editas Medicine has raised $214M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO. Investors on record include Bill Gates.

Editas Medicine at a glance

Total raised
$214M
Latest round
IPO
Industry
Biotech
Headquarters
Cambridge, Massachusetts
Notable investors
Bill Gates

Frequently asked about Editas Medicine funding

How much has Editas Medicine raised?
Editas Medicine has raised $214M in total disclosed funding across the rounds on record.
Who has invested in Editas Medicine?
Bill Gates are named among the investors backing Editas Medicine.
What was the latest Editas Medicine funding round?
The most recent disclosed round is an IPO.
Where is Editas Medicine based?
Editas Medicine is based in Cambridge, Massachusetts.
What sector does Editas Medicine operate in?
Editas Medicine is tracked under Biotech from Cambridge, Massachusetts, with $214M in disclosed funding.

Every Editas Medicine figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Cambridge at a similar stage.

Companies related to Editas Medicine (40)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades